You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中國醫療網絡(00383.HK)中期收入7.36億港元 同比增長3.54%
格隆匯 08-25 20:29

格隆匯8月25日丨中國醫療網絡(00383.HK)發佈公吿,截至2022年6月30日止6個月,實現收入總額7.36億港元,同比增長3.54%;公司股東應占虧損4390.2萬港元,同比收窄40.59%;基本每股虧損0.3港仙。董事會並不建議就截至2022年6月30日止6個月派付中期股息(2021年:無)。

於回顧期間內,營商環境受到中華人民共和國("中國")在南京新型冠狀病毒疫情造成的局部封鎖和社交限制、相應疫情防控措施及國家醫療衞生政策和醫保政策改革的不利影響。

扣除應收貸款減值虧損一次性非經常性項目後,公司擁有人應占虧損較2021年上半年公司擁有人應占虧損增加乃主要由於(i)醫療分部的南京醫院住院收入減少;(ii)醫療分部於修訂社會保險繳費工資基數後社會保險支出增加;(iii)醫療分部的高端綜合診所產生的經營前費用;(iv)護老分部及物業開發分部業務產生收入減少;(v)匯兑虧損淨額增加,惟部分被(vi)醫療分部門診及體檢服務收入增加所抵銷。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account